High-resolution three-dimensional chromatin profiling of the Chinese hamster ovary cell genome

Stephen Bevan1,2, Stefan Schoenfelder1,2, Robert J Young3

  • 1Nuclear Dynamics Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK.

Insights

Researchers mapped the 3D genome organization in Chinese hamster ovary (CHO) cells, improving genome assembly and identifying regulatory elements. This advances biotherapeutic production by enabling better CHO cell line development.

Area of Science:

  • Genomics
  • Cell Biology
  • Biotechnology

Background:

  • Chinese hamster ovary (CHO) cells are crucial for biopharmaceutical production of recombinant proteins.
  • Unpredictable transgene expression in CHO cells stems from poor understanding of genome organization and epigenetic repression.
  • Limited knowledge of CHO genome structure hinders functional genomics and cell line improvement.

Purpose of the Study:

  • To create an integrated 3D genome organization map for the CHOK1SV® 10E9 cell line.
  • To improve the CHOK1SV® 10E9 genome assembly.
  • To identify cis-regulatory elements and their interactions with promoters in 3D space.

Main Methods:

  • High-resolution chromatin conformation capture (Hi-C) datasets were generated.
  • An improved, chromosome-scale genome assembly was created for CHOK1SV® 10E9 cells.
  • Chromatin accessibility data was integrated with 3D genome organization data.

Main Results:

  • An integrative 3D genome map was generated, assigning ~90% of sequences to chromosome-scale assembly.
  • The map identified topologically associated domains and active cis-regulatory elements.
  • A 3D promoter interactome linked cis-regulatory elements to target promoters, demonstrating utility in analyzing transgene integration sites.

Conclusions:

  • The improved genome assembly and 3D map provide a foundation for functional genomics in CHO cells.
  • This work identifies novel targets for genome engineering to enhance biotherapeutic production.
  • The findings represent a significant advancement for CHO cell line development and industrial biomanufacturing.